Protocol summary
-
Study aim
-
Evaluation of the effect of dexmedetomidine on hemodynamic stability and opioid requirement in patients undergoing pulmonary hydatid cyst surgery
-
Design
-
A controlled, parallel-group, double-blind, block-randomized, phase 3 clinical trial on 40 patients. Block randomization using block sizes of 4 and 6 generated via the SealedEnvelope website will be applied.
-
Settings and conduct
-
This study will be conducted at Ghaem Hospital, Mashhad. Patients aged 18–65 undergoing unilateral pulmonary hydatid cyst surgery will be enrolled after informed consent and randomized using block randomization (blocks of 4 and 6 via SealedEnvelope). The intervention group receives dexmedetomidine, and the control group receives normal saline. Hemodynamic parameters are recorded at predefined times. Patients, the assessor, and the statistician are blinded, while the administering anesthesiologist is unblinded for safety.
-
Participants/Inclusion and exclusion criteria
-
Age 18 to 65 years, Candidate for unilateral pulmonary hydatid cyst surgery (thoracotomy or VATS), ASA class I–II, Having informed consent to participate.
-
Intervention groups
-
Intervention group: Will receive dexmedetomidine intravenously as a 1 µg/kg loading dose over 10 minutes, followed by a 0.5 µg/kg/h infusion until the end of surgery.
Control group: Similar to the intervention group, an equivalent volume of Normal Saline will be infused at the same rate.
-
Main outcome variables
-
Hemodynamic stability (blood pressure and heart rate); intraoperative opioid consumption; postoperative pain score (VAS); postoperative nausea and vomiting (PONV)
General information
-
Reason for update
-
Given that the initial registration of the study in the IRCT system was performed after obtaining the ethics approval and prior to the final approval by the University Research Council, the study start date entered at the time of initial registration was based on the preliminary version of the research proposal. Following further review by the Research Council and the application of the approved revisions, it became necessary to update this information to ensure full consistency between the registered data in IRCT and the final approved version of the research protocol.
The purpose of this update was to enhance transparency, scientific accuracy, and complete alignment between the IRCT registration and the final approved protocol as well as the actual conduct of the study. No changes have been made to the overall nature of the study, its primary objectives, or the ethical considerations of the research.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20250626066260N1
Registration date:
2025-11-21, 1404/08/30
Registration timing:
prospective
Last update:
2025-12-25, 1404/10/04
Update count:
1
-
Registration date
-
2025-11-21, 1404/08/30
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2026-02-20, 1404/12/01
-
Expected recruitment end date
-
2026-08-23, 1405/06/01
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery
-
Public title
-
Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Pulmonary Hydatid Cyst Surgery
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Age between 18 and 65 years
Candidate for unilateral pulmonary hydatid cyst surgery (via thoracotomy or VATS)
Physical status ASA class I or II
Written informed consent to participate in the study
Exclusion criteria:
-
Age
-
From 18 years old to 65 years old
-
Gender
-
Both
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Investigator
- Outcome assessor
-
Sample size
-
Target sample size:
40
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
In this study entitled “The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery,” block randomization was used. A total of 10 random blocks with variable block sizes of 4 and 6 and different random sequences were generated using the website https://www.sealedenvelope.com/simple-randomiser/v1/lists
. The contents of each block were placed in opaque, sealed, and sequentially numbered envelopes, and all blocks were randomly arranged. As each eligible patient was enrolled, the envelope corresponding to the current block was opened sequentially, and the patient was assigned to one of the two study arms (Dexmedetomidine group or Control group) according to the sequence inside. After completion of the first block, the next block was randomly selected, and this process continued until the last block was completed and the final patient was allocated. Consequently, patients were equally distributed between the two study arms, ensuring proper balance. The unit of randomization in this study was individual, and no stratified randomization was applied. For allocation concealment, the envelopes were prepared opaque, sealed, and sequentially numbered to prevent the investigator from knowing the intervention type prior to patient enrollment. The study was designed as a double-blind trial, in which both patients and the data analyst were blinded to group allocation, while the anesthesiologist administering the drug was aware of the allocation for safety monitoring and management of potential adverse effects.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
Participant: After receiving full information about the study protocol and providing written informed consent, participants remain unaware of their group allocation. Both dexmedetomidine and placebo solutions are prepared in identical syringes with the same volume and appearance by an independent staff member, ensuring that patients cannot distinguish their assigned intervention.
Investigator: The principal investigator does not participate in drug preparation or allocation procedures and remains blinded to group assignments throughout the data collection phase. Allocation codes are kept in sealed envelopes and will only be opened after completion of data analysis.
Outcome Assessor: The assessor responsible for recording hemodynamic variables, opioid consumption, postoperative pain scores, and clinical outcomes is fully blinded to the intervention type. The assessor works solely based on patient identification codes and has no access to information about drug assignment or administration.
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2025-10-27, 1404/08/05
-
Ethics committee reference number
-
IR.MUMS.IRH.REC.1404.191
Health conditions studied
1
-
Description of health condition studied
-
Pulmonary Hydatid Cyst
-
ICD-10 code
-
B67.4
-
ICD-10 code description
-
Echinococcus granulosus infection, unspecified
Primary outcomes
1
-
Description
-
Systolic and diastolic blood pressure
-
Timepoint
-
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
-
Method of measurement
-
Measurement of systolic and diastolic blood pressure using invasive and noninvasive automatic blood pressure monitor
2
-
Description
-
Heart rate
-
Timepoint
-
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
-
Method of measurement
-
Measurement of heart rate using an electrocardiographic cardiac monitor
3
-
Description
-
Total intraoperative opioid consumption
-
Timepoint
-
From the beginning of anesthesia induction until the end of the surgical procedure
-
Method of measurement
-
Calculation of the total opioid dose based on values recorded by the anesthesia team in the anesthesia record
Secondary outcomes
1
-
Description
-
Postoperative pain score measured by the Visual Analogue Scale
-
Timepoint
-
In the recovery room; two hours after surgery; four hours after surgery
-
Method of measurement
-
Measurement using a ten-centimeter Visual Analogue Scale for pain assessment
2
-
Description
-
Postoperative nausea and vomiting
-
Timepoint
-
In the recovery room; two hours after surgery; four hours after surgery
-
Method of measurement
-
Clinical observation and documentation of nausea and vomiting events by the recovery room nurse
3
-
Description
-
Sedation level assessed by the Ramsay Sedation Scale
-
Timepoint
-
In the recovery room; thirty minutes after admission to recovery
-
Method of measurement
-
Assessment using the Ramsay Sedation Scale
Intervention groups
1
-
Description
-
Intervention group: Includes patients who, after induction of anesthesia, receive dexmedetomidine initially at a dose of 1 µg/kg over 10 minutes, followed by 0.5 µg/kg/h via intravenous infusion until the end of surgery.
-
Category
-
Treatment - Drugs
2
-
Description
-
Control group: Includes patients who, under the same anesthetic conditions, receive an equivalent volume of normal saline instead of dexmedetomidine at the same infusion rate (placebo). Other anesthetic management and therapeutic interventions are the same as in the intervention group.
-
Category
-
Placebo
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Mashhad University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available